Casi de Young

Accenture Ltd. provides services to management consulting, technology services and outsourcing organizations. It provides management consulting, technology, systems integration and outsourcing services and solutions to the communications, electronics, high technology, media and entertainment industries. The company was founded in 1984 and is headquartered in Hamilton, Bermuda.

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.

ODC Therapy, Inc. operates offices of physical, occupational and speech therapists and audiologists. The company develops, produces and distributes customized cancer vaccines to individual patients and then monitors their immune response after treatment. The company was founded in 2004 and is headquartered in Dallas, TX.

Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.

ImmuneSensor Therapeutics, Inc. is a clinical-stage biotechnology company based in Dallas, TX. ImmuneSensor Therapeutics is building a pipeline of novel small molecule and adc immune stimulating candidates that aim to modulate the innate immune system. The company is led by a team of experienced biotech professionals who are committed to creating novel treatments that harness the body’s innate immune system to treat a wide range of diseases. ImmuneSensor Therapeutics is focused on discovering and developing novel therapies that leverage the incredible versatility and therapeutic potential of the cgas-sting pathway, which is one of the key pathways in the innate immunity system that works to detect both foreign and host-derived DNA. The company was founded in 2014 by Zhijian Chen and Jet Li, and the CEO is Ernest Wong.

Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX.